Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Balfour

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Pharmacoeconomics|April 8, 1993
Oral ciprofloxacin: a pharmacoeconomic evaluation of its use in the treatment of serious infectionsJ A Balfour, D Faulds
Drugs|March 1, 1996
MeloxicamS Noble, J A Balfour
Pharmacoeconomics|July 6, 1996
Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infectionsJ A Balfour, P Benfield
Drugs|February 1, 1992
Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycosesJ A Balfour, D Faulds
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 1, 1997
[Not Available]J A Balfour, P Benfield
Drugs & Aging|November 1, 1992
Transdermal estradiol. A review of its pharmacological profile, and therapeutic potential in the prevention of postmenopausal osteoporosisJ A Balfour, D McTavish
Pharmacoeconomics|August 6, 1995
Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infectionsR Davis, J A Balfour
American Journal of Clinical Dermatology|November 14, 2001
Topical eflornithineJ A Balfour, K McClellan
Drugs|December 1, 1993
Acarbose. An update of its pharmacology and therapeutic use in diabetes mellitusJ A Balfour, D McTavish
Drugs & Aging|September 18, 1998
RepaglinideJ A Balfour, D Faulds
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Pharmacoeconomics|April 8, 1993
Oral ciprofloxacin: a pharmacoeconomic evaluation of its use in the treatment of serious infectionsJ A Balfour, D Faulds
Drugs|March 1, 1996
MeloxicamS Noble, J A Balfour
Pharmacoeconomics|July 6, 1996
Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infectionsJ A Balfour, P Benfield
Drugs|February 1, 1992
Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycosesJ A Balfour, D Faulds
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 1, 1997
[Not Available]J A Balfour, P Benfield
Drugs & Aging|November 1, 1992
Transdermal estradiol. A review of its pharmacological profile, and therapeutic potential in the prevention of postmenopausal osteoporosisJ A Balfour, D McTavish
Pharmacoeconomics|August 6, 1995
Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infectionsR Davis, J A Balfour
American Journal of Clinical Dermatology|November 14, 2001
Topical eflornithineJ A Balfour, K McClellan
Drugs|December 1, 1993
Acarbose. An update of its pharmacology and therapeutic use in diabetes mellitusJ A Balfour, D McTavish
Drugs & Aging|September 18, 1998
RepaglinideJ A Balfour, D Faulds
Pageof 6